Andrea Charles | 09/12/2011
In this podcast Sudip Kumar Majumder, Principal Scientist at Intas Biopharmaceuticals India, speaks to Andrea Charles from Pharma IQ about streamlining and redesigning the downstream process and innovations on the horizon that will change the current state of play for biopharmaceutical downstream processing. Have Your Say Rate this feature and give us your feedback in the comments section below
To continue reading this story Click Here
RECOMMENDED
The Trust Equation: Why Transparency Defines the Future Winners in Contract Manufacturing
2025-12-17
Upcoming Events
DigIT Pharma & Health 2026
September 9 - 11, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More